Action 2289 CHARMACY PHARMACEUTICAL CO., LTD.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Charmacy Pharmaceutical Co., Ltd.

Actions

2289

CNE1000023D6

Temps Différé Hong Kong S.E.
Autres places de cotation
 07:30:37 10/05/2024 		Varia. 5j. Varia. 1 janv.
13,7 HKD -1,44% Graphique intraday de Charmacy Pharmaceutical Co., Ltd. +2,24% +5,71%
28/03 Charmacy Pharmaceutical Co. publie ses résultats pour l'exercice clos le 31 décembre 2023 CI
18/03 Le bénéfice de Charmacy Pharmaceutical chutera de 45 % en 2023 MT

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Charmacy Pharmaceutical 2023 Profit Declines on Lower Asset Disposal Gains
Charmacy Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 10 July 2024
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Charmacy Pharmaceutical’s Profit to Drop by 45% in 2023
Charmacy Pharmaceutical Meets Minimum Public Float Norms
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Charmacy Pharmaceutical Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2022, Payable on 31 July 2023
Charmacy Pharmaceutical Chairman Steps Down
Charmacy Pharmaceutical Co., Ltd. Announces Board Changes
Charmacy Pharmaceutical Co., Ltd. Announces Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on July 31, 2023
Charmacy Pharmaceutical's Controlling Shareholder Signs Letter of Commitment for Director Appointment; Shares Climb 6%
Charmacy Pharmaceutical Co., Ltd. Announces Resignation of Executives
Charmacy Pharmaceutical Co., Ltd. Recommends Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on 20 July 2023
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
Charmacy Pharmaceutical Renews Loan Provision Deal with Controlling Shareholder
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. completed the acquisition of 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. from a group of shareholders.
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. completed the acquisition of 9% of stake in Charmacy Pharmaceutical Co., Ltd. from Yao Chuanglong.
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. made an offer to acquire additional 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. from a group of shareholders for approximately HKD 250 million.
Charmacy Pharmaceutical Forecasts Increase in January-November Net Profit
Charmacy Pharmaceutical Co., Ltd. Provides Financial Guidance for the 11 Months Ended 30 November 2022
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 2289
  4. Actualités Charmacy Pharmaceutical Co., Ltd.
  5. Autres langues